Uraemic xerosis

Nephrology Dialysis Transplantation

Volumn 19, Issue 11, 2004, Pages 2709-2712

  Szepietowski, Jacek C ^a   Reich, Adam ^a   Schwartz, Robert A ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Emollients; Haemodialysis; Uraemic pruritus; Uraemic xerosis

Indexed keywords

2 ACETAMIDOETHANOL; EMOLLIENT AGENT; ETHANOLAMINE DERIVATIVE; PALMIDROL; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CLINICAL FEATURE; DRUG MECHANISM; FREQUENCY ANALYSIS; HEMODIALYSIS; HUMAN; PATHOGENESIS; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; PRURITUS; PSYCHOLOGICAL ASPECT; UREMIA; XEROSIS;

EMOLLIENTS; HUMANS; PRURITUS; RENAL DIALYSIS; SKIN DISEASES; UREMIA;

EID: 8344262362     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh480     Document Type: Article

References (30)

1. Bencini PL, Montagnino G, Citterio A et al. Cutaneous abnormalities in uremic patients. Nephron 1985; 40: 316-321
2. Silverberg NB, Singh A, Laude TA. Cutaneous manifestations of chronic renal failure in children of color. Pediatr Dermatol 2001; 18: 199-204
3. Szepietowski JC, Sikora M, Kunsztal M et al. Uremic pruritus: a clinical study of maintenance haemodialysis patients. J Dermatol 2002; 29: 621-627
4. Zucker I, Yosipovitch G, David M et al. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol 2003; 49: 842-846
5. Balaskas EV, Chu M, Uldall RP et al. Pruritus in continuous ambulatory peritoneal dialysis and haemodialysis patients. Perit Dial Int 1992; 13: 527S-532S
6. Morton CA, Lafferty M, Hau C et al. Pruritus and skin hydration during dialysis. Nephrol Dial Transplant 1996; 11: 2031-2036
7. Young A Jr, Sweeney E, David D et al. Dermatologic evaluation of pruritus in patients on hemodialysis. NY State J Med 1973; 73: 2670-2674
8. Ståhle-Bäckdahl M. Uremic pruritus. Clinical and experimental studies. Acta Derm Venereol 1989; 145: 1-38
9. Yosipovitch G, Reis J, Tur E et al. Sweat secretion, stratum corneum hydration, small nerve function and pruritus in patients with advanced chronic renal failure. Br J Dermatol 1995; 133: 561-564
10. Nielsen T, Hemmeloff-Andersen KE, Kristiansen J. Pruritus and xerosis in patients with chronic renal failure. Danish Med Bull 1980; 27: 269-271
11. Gilchrest BA, Rowe JW, Mihm MC. Clinical and histological cutaneous findings in chronic renal failure: evidence for a dialysis-resistant transplant-responsive microangiopathy. Lancet 1980; 2: 1271-1275
12. Southi P, Commens C. Pruritus in dialysis patients. Med J Aust 1987; 146: 397-398
13. Tercedor J, Lopez-Hernandez B, Rodenas JM et al. Multivariate analysis of cutaneous markers of aging in chronic hemodialysed patients. Int J Dermatol 1995; 34: 546-550
14. Tsukuhara K, Takema Y, Moriwaki S et al. Dermal fluid translocation is an important determinant of the diurnal variation in human skin thickness. Br J Dermatol 2001; 145: 590-596
15. Avermaete A, Altmeyer P, Bacharach-Buhles M. Skin changes and tumours after renal transplantation. Nephron 2002; 91: 188-196
16. Park T, Park C, Ha S et al. Dry skin (xerosis) in patients undergoing maintenance haemodialysis: the role of decreased sweating of the eccrine sweat gland. Nephrol Dial Transplant 1995; 10: 2269-2273
17. Cawley EP, Hoch-Bigeti C, Bondy GM. The eccrine sweat glands of patients in uremia. Arch Dermatol 1961; 84: 889
18. Landing BH, Wells TR, Williamson ML. Anatomy of eccrine sweat glands in children with chronic renal insufficiency and other fatal chronic disease. Am J Pathol 1970; 54: 15-21
19. Olstlere LS, Taylor C, Baillod R, Wright S. Relationship between pruritus, transepidermal water loss, and biochemical markers of renal itch in haemodialysis patients. Nephrol Dial Transplant 1994; 9: 1302-1304
20. Deleixhe-Mauhin, Piérard-Franchimont JM, Rorive G, Piérard GE. Biometrological evaluation of the stratum corneum texture in patients under maintenance hemodialysis. Nephron 1993; 64: 110-113
21. Weiss T, Windthorst C, Weiss C et al. Acute effects of haemodialysis on cutaneous microcirculation in patients with peripheral arterial occlusive disease. Nephrol Dial Transplant 1998; 13: 2317-2321
22. Sator P.-G, Schmidt JB, Hönigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 2003; 48: 352-358
23. Wasik F, Szepietowski J, Szepietowski T, Weyde W. Relief of uræmic pruritus after balneological therapy with a bath oil therapy containing polidocanol (Balneum Hermal Plus). An open clinical study. J Dermatol Treat 1996; 7: 231-233
24. Vahlquist A, Berne B, Berne C. Skin content and plasma transport of vitamin A and beta carotene in chronic renal failure. Eur J Clin Invest 1982; 12: 63-67
25. Urbonas A, Schwartz RA, Szepietowski JC. Uraemic pruritus - an update. Am J Nephrol 2001; 21: 343-350
26. Elias PM, Crumrine D, Rassner U et al. Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 2004; 122: 314-319
27. Löffler H, Effendy I. Prevention of irritant contact dermatitis. Eur J Dermatol 2002; 12: 4-9
28. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 1995; 92: 3376-3380
29. 9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur J Pharmacol 1997; 330: 231-240
30. Jaggar SI, Hasnie FS, Sellaturay S, Rice ASC. The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 1998; 76: 189-199